Yannick Hoffert, PharmD

Katholieke Universiteit Leuven, Belgium

Poster(s):

• P2629 - Clinical Validation of a Novel Software Tool to Guide the Intravenous-to-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET